AI Signal & Stock Analysis · Neutral →
As of Sep 28 2026, 6:09 PM, AkshayaAI's signal for VRTX is Neutral →; the stock is at $527.67 (+0.28% today); neutral (RSI 54); technical trend is Raise; news sentiment is positive.
Data as of Sep 28 2026, 6:09 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Neutral → |
|---|---|
| Price | $527.67 |
| Change today | +0.28% |
| RSI (14) | 54.24 |
| Relative volume | 0.59 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $133.7B |
| Forward P/E | 24.99 |
| 52-week high | -5.8% away |
| 52-week low | +39.0% above |
| Technical trend | RAISE-2026-09-28 |
| News sentiment | Positive |
| Sector | Healthcare-Biotech |
| Next earnings | 8/3/2026 4:30:00 PM |
As of Sep 28 2026, 6:09 PM, AkshayaAI assigns VRTX (Vertex Pharmaceuticals Inc) a Neutral signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
VRTX's RSI is neutral (RSI 54). A reading above 70 is typically considered overbought and below 30 oversold.
VRTX is trading about 6% below its 52-week high and 39% above its 52-week low as of Sep 28 2026, 6:09 PM.
VRTX's next earnings date is 8/3/2026 4:30:00 PM.
VRTX is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for VRTX — not personalised investment advice. Always do your own research.
REGN · ARGX · RVMD · ONC · ALNY · RPRX
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:09 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.